BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 19561458)

  • 1. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma.
    Halazun KJ; Hardy MA; Rana AA; Woodland DC; Luyten EJ; Mahadev S; Witkowski P; Siegel AB; Brown RS; Emond JC
    Ann Surg; 2009 Jul; 250(1):141-51. PubMed ID: 19561458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
    Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
    Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do preoperative inflammatory markers impact on outcome after liver transplantation for hepatocellular carcinoma?
    Sapisochin G; Yao FY; Roberts JP
    Ann Surg; 2011 Aug; 254(2):383; author reply 383-4. PubMed ID: 21694577
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preoperative neutrophil-lymphocyte ratio as a prognostic predictor after liver transplantation for hepatocellular carcinoma].
    Wang GY; Yang Y; Zhang Q; Li H; Chen GZ; Yi SH; Xu C; Wang GS; Zhang J; Yi HM; Jiang N; Fu BS; Zhao H; Li MR; Chen YH; Cai CJ; Lu MQ; Chen GH
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1519-22. PubMed ID: 21914362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study.
    Leung JY; Zhu AX; Gordon FD; Pratt DS; Mithoefer A; Garrigan K; Terella A; Hertl M; Cosimi AB; Chung RT
    Liver Transpl; 2004 Nov; 10(11):1343-54. PubMed ID: 15497158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
    Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
    Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation.
    Chen TM; Lin CC; Huang PT; Wen CF
    J Gastroenterol Hepatol; 2012 Mar; 27(3):553-61. PubMed ID: 21913982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
    Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
    Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
    Decaens T; Roudot-Thoraval F; Hadni-Bresson S; Meyer C; Gugenheim J; Durand F; Bernard PH; Boillot O; Sulpice L; Calmus Y; Hardwigsen J; Ducerf C; Pageaux GP; Dharancy S; Chazouilleres O; Cherqui D; Duvoux C
    Liver Transpl; 2006 Dec; 12(12):1761-9. PubMed ID: 16964590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma.
    Merli M; Nicolini G; Gentili F; Novelli G; Iappelli M; Casciaro G; Di Tondo U; Pecorella I; Marasco A; Onetti Muda A; Nudo F; Mennini G; Ginanni Corradini S; Riggio O; Berloco P; Attili AF; Rossi M
    Transplant Proc; 2005; 37(6):2535-40. PubMed ID: 16182736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammation-based scores do not predict post-transplant recurrence of hepatocellular carcinoma in patients within Milan criteria.
    Parisi I; Tsochatzis E; Wijewantha H; Rodríguez-Perálvarez M; De Luca L; Manousou P; Fatourou E; Pieri G; Papastergiou V; Davies N; Yu D; Luong T; Dhillon AP; Thorburn D; Patch D; O'Beirne J; Meyer T; Burroughs AK
    Liver Transpl; 2014 Nov; 20(11):1327-35. PubMed ID: 25088400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment.
    Motomura T; Shirabe K; Mano Y; Muto J; Toshima T; Umemoto Y; Fukuhara T; Uchiyama H; Ikegami T; Yoshizumi T; Soejima Y; Maehara Y
    J Hepatol; 2013 Jan; 58(1):58-64. PubMed ID: 22925812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
    Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
    Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to select suitable hepatocellular carcinoma for liver transplantation by preoperative neutrophil-lymphocyte ratio.
    Xiao GQ; Yan L; Yang J
    Hepatogastroenterology; 2014 Oct; 61(135):2077-83. PubMed ID: 25713913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma.
    Lee HH; Joh JW; Park JH; Lee KW; Heo JS; Choi SH; Kim SJ; Lee SK
    Transplant Proc; 2005 Mar; 37(2):1251-3. PubMed ID: 15848686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
    Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.